Monkeypox is not new, but the pattern of outbreak is new and unprecedented
The first human case of Monkeypox can be dated back to 1970. Democratic Republic of Congo was the first country to report Monkeypox in humans back then. Since then, the disease caused by Monkeypox virus remained rare and contained within in the regions of central and western African countries. The recent outbreak of Monkeypox disease…
News ViewsNew Patent granted for Thermally-controlled DNA synthesis technology by Evonetix
Evonetix Ltd has completed yet another milestone in its pursuit of reimagining biology with proprietary DNA synthesis technologies. The company’s thermally controlled technology for DNA synthesis is now patented in Europe. This includes the design and manufacturing of its silicon chips. Evonetix has been relentlessly pursuing the development of a benchtop DNA synthesis platform. Such…
Pramipexole-Rasagiline Combination Promising for Early Parkinson Disease Treatment
A novel combination of Pramipexole-Rasagiline is found to be promising in a recently concluded clinical trial for Early Parkinson Disease treatment. Top line results from this Phase III trial indicate the superiority of fixed-dose combination of extended release (ER) formulations of pramipexole and rasagiline (P2B001) in adults with early Parkinson disease. P2B001 has successfully met…
Molnupiravir for COVID-19 – Is it a Magic Pill or just a Hype in the Making?
Merck’s Molnupiravir, an oral antiviral treatment is set for review by the FDA Advisory Panel. If approved, Molnupiravir will be the first oral antiviral treatment authorized for the treatment of COVID-19. This experimental drug was developed by Merck and Ridgeback Biotherapeutics. This comes at the back drop of several drugs failing to prove their efficacy,…
Treating End-Stage Recurrent Glioblastoma with Oscillating Magnetic Field Therapy
Can a magnetic helmet treat cancerous tumors? A recent outcome from a human test of an investigational magnetic device indicates its possibility. In July 2021, a case report published in ‘Frontiers in Oncology’ confirms promising outcome of using an Oncomagnetic Device to treat Glioblastoma. It is an aggressive form of cancer that affects brain or…
Are they Harmful or Beneficial? Recent study outcomes of using Statins
The use of Statins has been a subject of worldwide debate among the medical professionals, especially the Cardiovascular Practitioners. Some physicians are even known for putting out notices mentioning they won’t prescribe Statins in their respective clinics. What makes them so controversial? If going by the side-effects, virtually every class of drugs comes with their…
Antibiotics and Cancer? Understanding Antibiotics from the perspective of Cancer Risk
What causes Cancer? The ultimate causes of Cancer have been studied for decades and there doesn’t seem to be a single cause to isolate. Many conclusive studies point towards Genetics related to Hereditary and Lifestyle related to Alcohol and Tobacco, among the many causes or risk factors. Excess use or unguided use of Antibiotics is…
Controversy around the newly approved Alzheimer’s drug by Biogen
Aduhelm is the first drug approved for Alzheimer’s since 2003, which has immediately become a controversy. While some call it a breakthrough, there are experts who consider the evidence is not good enough for the FDA approval. Aducanumab is its generic name which was granted accelerated approval. Alzheimer’s disease is often referred as a devastating…
Ever growing prominence of mRNA in the development of global vaccines
mRNA is one of the three types of RNA that is found in an animal cell. The molecular biology and genetic studies have clearly concluded the role of mRNA in the formation of amino acids. The process is also known as protein synthesis. mRNA is identical to a single strand of DNA with its own…
News Views